Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Other Non-Current Liabilities (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Other Non-Current Liabilities for 12 consecutive years, with $72000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities changed 0.0% year-over-year to $72000.0, compared with a TTM value of $72000.0 through Sep 2025, changed 0.0%, and an annual FY2024 reading of $72000.0, down 65.71% over the prior year.
  • Other Non-Current Liabilities was $72000.0 for Q3 2025 at Lisata Therapeutics, roughly flat from $72000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $337000.0 in Q1 2023 and bottomed at $72000.0 in Q3 2024.
  • Average Other Non-Current Liabilities over 3 years is $158000.0, with a median of $119000.0 recorded in 2024.
  • The sharpest move saw Other Non-Current Liabilities tumbled 71.54% in 2024, then changed 0.0% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $210000.0 in 2023, then tumbled by 65.71% to $72000.0 in 2024, then changed by 0.0% to $72000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for LSTA at $72000.0 in Q3 2025, $72000.0 in Q2 2025, and $72000.0 in Q1 2025.